US submits extradition request for Kobi Alexander

By JPOST.COM STAFF, AP
October 23, 2006 13:14

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

The United States submitted a request to Namibia on Monday for the extradition of fugitive Comverse CEO Ya'akov (Kobi) Alexander. The request came four days before the official cutoff date for such an appeal. Namibia's justice minister was expected to convene an emergency discussion on the extradition request on Tuesday. Alexander, who was accused in a multimillion-dollar stock manipulating scheme, was released on bail earlier this month by a Namibian judge. The Namibian government said at the time that it opposed bail pending a formal extradition request from the US, according to Justice Ministry official Dennis Khama. Earlier, US Attorney Roslynn Mauskopf said that she would seek Alexander's swift extradition to face charges in federal court in Brooklyn.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS